N-(3-hydroxyphenyl)-5-methyl-3-isoxazolecarboxamide, 95.0%, 5g

[4-(4-fluorophenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]acetic acid, 250mg

(R)-(-)-2-(4-Ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetic acid, 96%, 1g

4-Bromobenzenediazonium Tetrafluoroborate>97.0%(HPLC)(T)5g

2-(4-bromophenyl)-1,4-dihydroquinazolin-4-one, 97%, 5g

2-Methyl-2H-pyrazolo[3,4-B]pyridine-5-boronic acid, 95.0%, 25g

Chloromethylpentamethyldisiloxane, 95%, 1g

2-Amino-6-hydroxy-4-methylpyrimidine, 95.0%, 10g

2-Methyl-imidazo[2,1-b]thiazole-5-carboxylic acid ethyl ester, 95%+, 5g

1,3-Bis(trifluoromethyl)benzene>98.0%(GC)25g

Methyl 5-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate, 97%, 1g

2,2,3,3,4,4,5,5,6,6,7,7,8,8-Tetradecafluoro-1,9-nonanediol, 90.0%, 1g

3-Chloro-6-phenylpyridazine, 95.0%, 1g